Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. (Q51365744)
Jump to navigation
Jump to search
scientific article published on 22 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. |
scientific article published on 22 December 2011 |
Statements
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. (English)
1 reference
J Wainstein
1 reference
L Katz
1 reference
S S Engel
1 reference
L Xu
1 reference
G T Golm
1 reference
S Hussain
1 reference
E A O'Neill
1 reference
K D Kaufman
1 reference
B J Goldstein
1 reference
22 December 2011
1 reference
14
1 reference
5
1 reference
409-418
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference